Electron microscopy of superficial bladder tumours and urothelium after intravesical doxorubicin

Area of Science:

• Oncology
• Cell Biology
• Urology

Background:

• Superficial transitional cell carcinomas (TCCs) are the most common type of bladder cancer.
• Intravesical chemotherapy is a standard treatment for non-muscle invasive bladder cancer.
• Doxorubicin is a commonly used chemotherapeutic agent in intravesical therapy.

Purpose of the Study:

• To investigate the ultrastructural effects of intravesical doxorubicin on superficial TCC cells and adjacent urothelium.
• To elucidate the mechanisms of doxorubicin-induced cell damage and death in the bladder.

Main Methods:

• Electron microscopy was used to examine cellular changes.
• Tissues from superficial TCC and adjacent urothelium treated with intravesical doxorubicin were analyzed.

Main Results:

• Key cellular damage patterns included nucleolar segregation, cytoplasmic vacuolation, and mitochondrial abnormalities.
• Breakdown of secondary lysosomes led to autolysis (self-digestion) of cells.
• Cell loss occurred via desquamation (shedding) from the surface and random cell death in deeper layers.

Conclusions:

• Intravesical doxorubicin induces significant ultrastructural damage to both tumor cells and normal urothelium.
• The observed cellular damage and death mechanisms contribute to the efficacy of intravesical doxorubicin therapy.
• Understanding these effects aids in optimizing bladder cancer treatment strategies.